Centrum für Hämatologie und Onkologie Bethanien
Hospital
Location:
Frankfurt a. M.,
Germany (DE)
ISNI: -
Surgical outcome after neoadjuvant chemotherapy and bevacizumab: results from the GeparQuinto study (GBG 44) (2014)
Gerber B, Von Minckwitz G, Eidtmann H, Rezai M, Fasching P, Tesch H, Eggemann H, et al.
Journal article
Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40--GeparQuattro) (2014)
Von Minckwitz G, Rezai M, Fasching P, Huober J, Tesch H, Bauerfeind I, Hilfrich J, et al.
Journal article
Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial (2010)
Witzel I, Loibl S, Von Minckwitz G, Mundhenke C, Huober J, Hanusch C, Henschen S, et al.
Journal article